Latest News
Press background on OncoStem Diagnostics
Company profile
OncoStem Diagnostics, founded by Dr. Manjiri Bakre, develops innovative multi-marker prognostic tests to enable personalized treatment of cancer patients. OncoStem’s ‘CanAssist Breast’ is an innovative, cost effective test that can help clinicians to plan tailor made treatment for each breast cancer patient based on tumor biology. The risk of cancer recurrence is dependent on tumor type, stage and on the biology of each patient’s tumor. ‘CanAssist-Breast’ determines the proteomic fingerprint of the tumor. This information is then used by OncoStem’s proprietary machine learning-based algorithm that stratifies patients as ‘low-or-high’ risk for cancer recurrence. Patients classified as ‘high-risk’ would have a greater probability of the cancer recurring than those classified as low-risk. This will guide clinicians in planning treatment and help patients in understanding the prognosis of their disease.
 Recent press releases
OncoStem Diagnostics Wins Aegis Graham Bell Award in the Innovative Diagnostics Category

OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment has been recognised as the winner of Aegis Graham Bell Award in the Innovative Diagnostics Category. The award is an initiative by Aegis School of Data Science to honour innovations in IT, Telecom a... (more)
Share
Dr. Manjiri Bakre of OncoStem Diagnostics Recognised as One Among the Top 25 Voices in Precision Medicine Asia

Dr. Manjiri Bakre, CEO and Founder of Bengaluru-based oncology focused company OncoStem Diagnostics, has been recognised as one among the top 25 Voices in Precision Medicine Asia, an elite compendium of thought leaders in precision medicine across Asia. An initiative by BIS Research and Ins... (more)
Share
New Study Reports OncoStem's CanAssist Breast Equivalent to Gold Standard

OncoStem Diagnostics, an oncology-focused company that enables personalised cancer treatment, has successfully completed its first-ever comparative study with the prognostic test Oncotype DX. The study, conducted using samples from OncoStem’s study partners in India, USA and Spain, wa... (more)
Share
Dr. Manjiri Bakre Awarded 'Health Tech Innovator of the Year'

Dr. Manjiri Bakre, Founder & CEO OncoStem Diagnostics, was awarded ‘Health Tech Innovator of the Year’ by ET Healthworld - Intelligent Health & Tech awards 2020.
 
Personalize Your Cancer Treatment
 
YouTube Video Link: yout... (more)
Share
OncoStem Diagnostics Wins CII's Startupreneur Award in Biotech and Pharma Category

OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment has won the Startupreneur Award organized by CII (Confederation of Indian Industry) in the Biotech and Pharma Category, for its innovative prognostic test ‘CanAssist Breast’.
... (more)
Share
New Age Technology can Help Indian Cancer Patients Save a Lot of Money

OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment, is pleased to announce the publication of a review paper on the impact of over treatment of Early stage breast cancer on patients. The review indicates that in early-stage breast cancer where the r... (more)
Share